Spire Healthcare Group
plc
('Spire Healthcare', 'the
Company' or 'the Group')
Notice of Interim
Results
15
August 2024
Spire Healthcare Group plc (LSE:
SPI), a leading independent healthcare group in the United Kingdom,
will announce its interim results for the six months ended 30 June
2024 on Thursday, 12 September 2024.
A presentation for sell-side
analysts and institutional investors will be held on the day of the
interim results announcement at 9.00am (BST) at the offices of
Instinctif Partners, 65 Gresham Street, London, EC2V 7NQ.
Refreshments will be available from 8.30am (BST). If you wish to
attend the presentation, please contact Instinctif Partners
at spire@instinctif.com.
Following the presentation, there
will be a moderated Q&A session.
For those who cannot attend in
person, the presentation will also be accessible via live Zoom
webcast.
Click the following link to register
in advance for the Zoom webcast and to receive access
details:
https://spirehealthcare.zoom.us/webinar/register/WN_lnWbJHGcQs2BHYE8b9lcTA
A recording of the webcast will be
made available from 1.00pm (BST) on 12 September on the Spire
Healthcare website, https://www.investors.spirehealthcare.com
- Ends -
For
further information please contact:
|
Spire Healthcare
Angus Prentice - Director of
Investor Relations
|
+44 (0)7974 982 512
|
|
Instinctif Partners
Julian Walker
Guy
Scarborough
|
+44 (0)7825 189 696
+44 (0)7917 178 920
|
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number
09084066
About Spire Healthcare
Spire
Healthcare is a leading
independent healthcare group in the United Kingdom, running 39
hospitals and over 50 clinics, medical centres and consulting rooms
across England, Wales and Scotland. It operates a network of
private GPs and provides occupational health services to over 800
corporate clients.
Working in partnership with over
8,600 experienced consultants, Spire Healthcare delivered tailored,
personalised care to over 1 million inpatients, outpatients and
daycase patients, and occupational health programme clients, in
2023, and is the leading private provider, by volume, of
knee and
hip operations in the United
Kingdom. It also delivers a range of private and NHS mental health,
musculoskeletal and dermatological services under the Vita Health
Group brand.
Spire Healthcare's well-located and
scalable hospitals have delivered successful and award-winning
outcomes, positioning the group well with patients, consultants,
the NHS, GPs and Private Medical Insurance ('PMI') providers. 98%
of Spire Healthcare's inspected locations are rated 'Good',
'Outstanding' or the equivalent by health inspectors in England,
Wales and Scotland.
Spire Healthcare is listed on the
London Stock Exchange and is a member of the FTSE 250.